Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells.

Bhatt AS, Takeuchi T, Ylstra B, Ginzinger D, Albertson D, Shuman MA, Craik CS.

Biol Chem. 2003 Feb;384(2):257-66.

PMID:
12675519
2.

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A.

Int J Oncol. 2009 Jan;34(1):15-23.

PMID:
19082473
3.
4.
5.

Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma.

Zannetti A, Del Vecchio S, Carriero MV, Fonti R, Franco P, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M.

Cancer Res. 2000 Mar 15;60(6):1546-51.

6.

The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma.

Santin AD, Cane' S, Bellone S, Bignotti E, Palmieri M, De Las Casas LE, Anfossi S, Roman JJ, O'Brien T, Pecorelli S.

Cancer. 2003 Nov 1;98(9):1898-904.

7.

In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.

Bhuvarahamurthy V, Schroeder J, Denkert C, Kristiansen G, Schnorr D, Loening SA, Jung K, Staack A.

Oncol Rep. 2004 Oct;12(4):909-13.

PMID:
15375521
8.
9.

Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression.

Serratì S, Margheri F, Fibbi G, Di Cara G, Minafra L, Pucci-Minafra I, Liotta F, Annunziato F, Pucci M, Del Rosso M.

J Pathol. 2008 Apr;214(5):545-54. doi: 10.1002/path.2309.

PMID:
18189329
10.

Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies.

Sun J, Pons J, Craik CS.

Biochemistry. 2003 Feb 4;42(4):892-900.

PMID:
12549907
11.

T-SP1: a novel serine protease-like protein predominantly expressed in testis.

Neth P, Profanter B, Geissler C, Nägler DK, Nerlich A, Sommerhoff CP, Jochum M.

Biol Chem. 2008 Dec;389(12):1495-504. doi: 10.1515/BC.2008.170.

PMID:
18844450
12.

Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.

Bhuvarahamurthy V, Schroeder J, Kristiansen G, Roigas J, Denkert C, Johannsen M, Lein M, Loening SA, Schnorr D, Jung K, Staack A.

Oncol Rep. 2005 Sep;14(3):777-82.

PMID:
16077991
13.

Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.

Li P, Gao Y, Ji Z, Zhang X, Xu Q, Li G, Guo Z, Zheng B, Guo X.

J Pediatr Surg. 2004 Oct;39(10):1512-9.

PMID:
15486896
14.

Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.

Warnecke-Eberz U, Prenzel KL, Baldus SE, Metzger R, Dienes HP, Bollschweiler E, Hoelscher AH, Schneider PM.

Pancreas. 2008 Mar;36(2):173-7. doi: 10.1097/MPA.0b013e31815ac538.

PMID:
18376309
15.

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

17.

Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.

Kirchhofer D, Peek M, Li W, Stamos J, Eigenbrot C, Kadkhodayan S, Elliott JM, Corpuz RT, Lazarus RA, Moran P.

J Biol Chem. 2003 Sep 19;278(38):36341-9.

18.

Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis.

Seitz I, Hess S, Schulz H, Eckl R, Busch G, Montens HP, Brandl R, Seidl S, Schömig A, Ott I.

Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):769-75.

19.

Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.

Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.

Int J Oncol. 2006 Apr;28(4):807-14.

PMID:
16525628
20.

Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients.

Parr C, Sanders AJ, Davies G, Martin T, Lane J, Mason MD, Mansel RE, Jiang WG.

Clin Cancer Res. 2007 Jun 15;13(12):3568-76.

Items per page

Supplemental Content

Support Center